Ghent University Academic Bibliography

Journal Article
A1
open access

Community pharmacist counseling improves adherence and asthma control : a nationwide study

Barbara Putman, Louise Coucke, Anna Vanoverschelde (UGent) , Els Mehuys (UGent) and Lies Lahousse (UGent)

(2022) BMC HEALTH SERVICES RESEARCH. 22(1).

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(1). p.S1-S18

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 205(1). p.17-35

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) RESPIROLOGY. 27(1). p.14-35

Add to list

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) ARCHIVOS DE BRONCONEUMOLOGIA. 58(1). p.35-51

Add to list

Journal Article
A1
open access

Unlocking the secrets of long non-coding RNAs in asthma

Fien Gysens (UGent) , Pieter Mestdagh (UGent) , Eric de Bony de Lavergne (UGent) and Tania Maes (UGent)

(2022) THORAX. 77(5). p.514-522

Add to list

Journal Article
A1
open access

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Debbie J. Maurer, Chengyao Liu, Paraskevi Xepapadaki, Barbara Stanic, Claus Bachert (UGent) , Susetta Finotto, Ya‐Dong Gao, Anna Graser, Tuomas Jartti, Walter Kistler, et al.

(2022) ALLERGY. 77(4). p.1216-1230

Add to list

Journal Article
A1
open access

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244

Add to list

Journal Article
A1
open access

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, Nobuo Ohta, Mikiya Asako, Claus Bachert (UGent) , Tomoyuki Inoue, Yoshinori Takahashi, Hiroyuki Fujita, Yamo Deniz, et al.

(2022) ALLERGY. 77(1). p.186-196

Add to list

Journal Article
A1
open access

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert, Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526

Academic Bibliography

Community pharmacist counseling improves adherence and asthma control : a nationwide study

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Unlocking the secrets of long non-coding RNAs in asthma

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Contents

Support

Contact